The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
Open accessAbstract
Objective: Acute kidney injury requiring renal replacement therapy in severe vasodilatory shock is associated with an unfavorable prognosis. Angiotensin II treatment may help these patients by potentially restoring renal function without decreasing intrarenal oxygenation. We analyzed the impact of angiotensin II on the outcomes of acute kidney injury requiring renal replacement therapy. Design: Post hoc analysis of the Angiotensin II for the Treatment of High-Output Shock 3 trial. Setting: ICUs. Patients: Patients with acute kidney injury treated with renal replacement therapy at initiation of angiotensin II or placebo (n = 45 and n = 60, respectively). Interventions: IV angiotensin II or placebo. Measurements and Main Results: Primary end point: survival through day 28; secondary outcomes included renal recovery through day 7 and increase in mean arterial pressure from baseline of ≥ 10 mm Hg or increase to ≥ 75 mm Hg at hour 3. Survival rates through day 28 were 53% (95% CI, 38%–67%) and 30% (95% CI, 19%–41%) in patients treated with angiotensin II and placebo (p = 0.012), respectively. By day 7, 38% (95% CI, 25%–54%) of angiotensin II patients discontinued RRT versus 15% (95% CI, 8%–27%) placebo (p = 0.007). Mean arterial pressure response was achieved in 53% (95% CI, 38%–68%) and 22% (95% CI, 12%–34%) of patients treated with angiotensin II and placebo (p = 0.001), respectively. Conclusions: In patients with acute kidney injury requiring renal replacement therapy at study drug initiation, 28-day survival and mean arterial pressure response were higher, and rate of renal replacement therapy liberation was greater in the angiotensin II group versus the placebo group. These findings suggest that patients with vasodilatory shock and acute kidney injury requiring renal replacement therapy may preferentially benefit from angiotensin II.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Cellular pathophysiology of ischemic acute kidney injury
Bonventre, J. V., & Yang, L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45161 · Cited by 2,019
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
Chawla, L. S., Eggers, P. W., Star, R. A., & Kimmel, P. L. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1214243 · Cited by 1,977
Self-citationComparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
16., O. B. O. T. A. D. Q. I. W., Chawla, L. S., Bellomo, R., Bihorac, A., Goldstein, S. L., Siew, E. D., Bagshaw, S. M., Bittleman, D., Cruz, D., Endre, Z., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.2 · Cited by 1,537
Self-citationVincent, J.-L., & De Backer, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208943 · Cited by 1,425
Initiation strategies for renal-replacement therapy in the intensive care unit.
Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603017 · Cited by 1,243
Zarbock, A., Kellum, J. A., Schmidt, C., Van Aken, H., Wempe, C., Pavenstädt, H., Boanta, A., Gerß, J., & Meersch, M. (2016) · JAMA · doi:10.1001/jama.2016.5828 · Cited by 1,143
Self-citationThe Pathogenesis of Vasodilatory Shock
Landry, D. W., & Oliver, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002709 · Cited by 1,136
Cited by
Peerapornratana, S., Manrique-Caballero, C. L., Gómez, H., & Kellum, J. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.026 · Cited by 1,471
Sepsis associated acute kidney injury
Poston, J. T., & Koyner, J. L. (2019) · BMJ · doi:10.1136/bmj.k4891 · Cited by 818
Zarbock, A., Nadim, M. K., Pickkers, P., Gomez, H., Bell, S., Joannidis, M., Kashani, K., Koyner, J. L., Pannu, N., Meersch, M., et al. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00683-3 · Cited by 767
Self-citationAcute kidney injury in the critically ill: an updated review on pathophysiology and management
Pickkers, P., Darmon, M., Hoste, E., Joannidis, M., Legrand, M., Ostermann, M., Prowle, J. R., Schneider, A., & Schetz, M. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06454-7 · Cited by 549
Self-citationOstermann, M., Lumlertgul, N., Jeong, R., See, E., Joannidis, M., & James, M. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02385-7 · Cited by 396
Self-citation
Metadata
- Authors
- Tumlin, J. A., Murugan, R., Deane, A. M., Ostermann, M., Busse, L. W., Ham, K. R., Kashani, K., Szerlip, H. M., Prowle, J. R., Bihorac, A., Finkel, K. W., Zarbock, A., Forni, L. G., Lynch, S. J., Jensen, J., Kroll, S., Chawla, L. S., Tidmarsh, G. F., & Bellomo, R.
- Venue
- Critical Care Medicine
- Published
- 2018-06
- Volume
- 46
- Issue
- 6
- Pages
- 949-957
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2789446953
- Cited by
- 291
- References
- 39
- FWCI
- 21.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II. https://app.cochat.ai/papers/10.1097/ccm.0000000000003092
- The paper
- Tumlin, J. A., Murugan, R., Deane, A. M., Ostermann, M., Busse, L. W., Ham, K. R., Kashani, K., Szerlip, H. M., Prowle, J. R., Bihorac, A., Finkel, K. W., Zarbock, A., Forni, L. G., Lynch, S. J., Jensen, J., Kroll, S., Chawla, L. S., Tidmarsh, G. F., & Bellomo, R. (2018). Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II. Critical Care Medicine. https://doi.org/10.1097/ccm.0000000000003092
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.